youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
CBRE:NYSE
CBRE Group Inc
$134.23
arrow_upward
+2.65%(+3.46) 1D
$134.23
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 20, 4:02:58 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CBRE...
Open
$132.05
High
$136.68
Low
$130.86
Mkt. cap
38.87B
Avg. vol.
2.10M
Volume
3.24M
P/E ratio
30.78
52-wk high
$174.27
52-wk low
$121.69
EPS
$4.36
Beta
1.23
Shares outstanding
289.58M
No. of employees
155K
Open
$132.05
High
$136.68
Low
$130.86
Mkt. cap
38.87B
Avg. vol.
2.10M
Volume
3.24M
P/E ratio
30.78
52-wk high
$174.27
52-wk low
$121.69
EPS
$4.36
Beta
1.23
Shares outstanding
289.58M
No. of employees
155K
News stories
From web sources and news partners
Investing.com Canada
·
32 minutes ago
Form 8K CBRE Group Inc For: 20 October By Investing.com
News Corp
·
56 minutes ago
CBRE Group Inc. Cl A stock outperforms competitors on strong trading day
ad-hoc-news.de
·
2 hours ago
Jefferies cuts target for CBRE Group stock to USD 164.00
The Business Journals
·
3 hours ago
Urban office outpaces suburbs as office market remains flat overall
Profile
CBRE Group, Inc. is an American commercial real estate services and investment firm, with corporate headquarters in Dallas, Texas, and global financial headquarters at Lever House in Midtown Manhattan. It is the world's largest commercial real estate services and investment firm based on 2025 revenue.
The firm is ranked 118th on the Fortune 500 and has been included every year since 2008. CBRE serves approximately 90 of the companies on the Fortune 100. It is one of the major commercial real estate brokerage firms, alongside JLL, Cushman & Wakefield and Newmark Group. Wikipedia
About CBRE Group Inc
Analyst ratings
Based on 8 analysts giving stock ratings to CBRE in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CBRE in the last 3 months.
Highest
Current $134.23
$190.00 (+41.55%)
Average
$182.57 (+36.01%)
Lowest
$164.00 (+22.18%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Anthony Paolone J.P. Morgan | Buy | Maintained | $186.00 | +38.6% | 10/13/2026 |
Jade Rahmani KBW | Buy | Maintained | $164.00 | +22.2% | 10/08/2026 |
Julien Blouin Goldman Sachs | Buy | Maintained | $190.00 | +41.5% | 08/18/2026 |
Brendan Lynch Barclays | Buy | Maintained | $183.00 | +36.3% | 08/17/2026 |
Seth Bergey Citi | Buy | Maintained | $190.00 | +41.5% | 08/03/2026 |
Alex Kramm UBS | Buy | Maintained | $190.00 | +41.5% | 07/30/2026 |
Steve Sakwa Evercore ISI | Buy | Maintained | $175.00 | +30.4% | 07/30/2026 |
Stephen Sheldon William Blair | Buy | Maintained | - | - | 07/29/2026 |
Benjamin Toms RBC Capital | Hold | Downgraded | - | - | 07/07/2026 |
Ronald Kamdem Morgan Stanley | Buy | Reiterated | $180.00 | +34.1% | 06/18/2026 |
Joe Dickstein Jefferies | Buy | Reiterated | $170.00 | +26.6% | 05/05/2026 |
Next call in 38:39:32
Thu, Oct 22, 2:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $1.96
Revenue / Est. (USD)
- / 11.89B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 10.26B | 11.63B | 10.53B | 11.23B |
Cost of goods sold | 8.30B | 9.47B | 8.68B | 9.14B |
Cost of revenue | 8.30B | 9.47B | 8.68B | 9.14B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 1.27B | 1.95B | 1.39B | 1.49B |
Operating expense | 1.45B | 2.14B | 1.57B | 1.68B |
Total operating expenses | 9.75B | 11.62B | 10.25B | 10.82B |
Operating income | 505.00M | 14.00M | 279.00M | 405.00M |
Other non operating income | 3.00M | 9.00M | 11.00M | 6.00M |
EBT including unusual items | 487.00M | 564.00M | 454.00M | 315.00M |
EBT excluding unusual items | 511.00M | -44.00M | 222.00M | 355.00M |
Income tax expense | 91.00M | 114.00M | 112.00M | 68.00M |
Effective tax rate | 18.69% | 20.21% | 24.67% | 21.59% |
Other operating expenses | - | - | - | - |
Net income | 363.00M | 416.00M | 318.00M | 204.00M |
Net profit margin | 3.54% | 3.58% | 3.02% | 1.82% |
Earnings per share | 1.61 | 2.73 | 1.61 | 1.56 |
Interest and investment income | - | - | - | - |
Interest expense | -50.00M | -57.00M | -59.00M | -60.00M |
Net interest expenses | -50.00M | -57.00M | -59.00M | -60.00M |
Depreciation and amortization charges | 181.00M | 189.00M | 182.00M | 190.00M |
EBITDA | 735.00M | 250.00M | 512.00M | 645.00M |
Gain or loss from assets sale | - | -459.00M | -301.00M | -5.00M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1